drugset / Trial / NCT04717362
The Effects of Natesto For Treatment Of Hypogonadism
NaSingle-groupOpen-labelTreatment
Summary
In this prospective study, the investigators plan is to confirm the role of Natesto (intranasal testosterone) to combat hypogonadal symptoms in men trying to recover spermatogenesis following the withdrawal of conventional Testosterone replacement therapy.
Timeline
- Start
- 2024-03-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Testosterone | Small molecule | 5.5 mg | Intranasal |